Texray AB | Gothenburg, Sweden | April 7, 2022 |

Co-founding duo Petra Apell and Fredrik Gellerstedt have been invited to join as Faculty members to the 44th International Charing Cross (CX) Vascular and Endovascular Symposium Challenges Update, London, UK.

Texray previously participated in the 2019 edition of the ‘Dragons Den’ competition hosted by CX and won the prestigious innovation awards.  Petra and Fredrik are now returning to CX to give a presentation on April 28th on the latest data from Texray.

“I was one of the dragons at CX in 2019 when Texray won the best innovation award and since then, I knew that this company will become successful! I very much look forward to – together with team Texray – continue striving for an improved working environment for the ones who save the lives of others”, says Jeffrey B. Jump, Chairman of the Board at Texray.


Charing Cross International Symposium (CX) is the leading vascular symposium where Education, Innovation and Evidence come together. The CX Symposium continues its three-year cycle of raising vascular and endovascular controversies to challenge the available evidence and be able to reach a consensus after discussion with an expert audience. This year, the world-class faculty focuses on addressing the most pressing challenges affecting all aspects of vascular disease management across the core areas of our Symposium: Aortic, Peripheral, Venous, Acute Stroke, Vascular Access and the new topic, The Hurting Leg.